Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
Home »
Publications » Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
Publish Date 06/06/2024
Category
Keywords
Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
Join the Arbor Assays Newsletter
Sign up for Arbor Assays’ email list to stay up to date on special deals, new kits, and published articles featuring Arbor Assays’ products
